Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vanda Pharmaceuticals (VNDA) Change in Taxes (2010 - 2011)

Vanda Pharmaceuticals recorded quarterly Change in Taxes of -$2.1 million in Q4 2011, down 1765.49% quarter-over-quarter from -$113000.0 in Q3 2011, and down 417.95% year-over-year from $663000.0 in Q4 2010.

Vanda Pharmaceuticals' Change in Taxes history runs 2 years deep, the most recent figure standing at -$2.1 million for Q4 2011.

  • In Q4 2011, Change in Taxes fell 417.95% year-over-year to -$2.1 million; the TTM figure through Dec 2011 stood at -$2.3 million (changed N/A YoY), while the FY2011 annual figure was -$2.3 million, down 158.13% from the prior year.
  • Change in Taxes came in at -$2.1 million for Q4 2011 at Vanda Pharmaceuticals, down from -$113000.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $663000.0 in Q4 2010 to a low of -$2.5 million in Q3 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Taxes (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Vanda Pharmaceuticals 379.35 Mn 177.04 Mn 48.56 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2011 -2.11 Mn
Dec 31, 2011 -2.11 Mn
Sep 30, 2011 -113,000.00
Sep 30, 2011 -113,000.00
Jun 30, 2011 -51,000.00
Jun 30, 2011 -51,000.00
Mar 31, 2011 6,000.00
Mar 31, 2011 6,000.00
Dec 31, 2010 663,000.00
Dec 31, 2010 663,000.00
Sep 30, 2010 -2.53 Mn
Sep 30, 2010 -2.53 Mn